These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 33004830

  • 1. A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
    Herrera-Rios D, Li G, Khan D, Tsiampali J, Nickel AC, Aretz P, Hewera M, Suwala AK, Jiang T, Steiger HJ, Kamp MA, Muhammad S, Hänggi D, Maciaczyk J, Zhang W, Kahlert UD.
    Sci Rep; 2020 Oct 01; 10(1):16218. PubMed ID: 33004830
    [Abstract] [Full Text] [Related]

  • 2. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D.
    Stem Cells; 2014 Jan 01; 32(1):301-12. PubMed ID: 24038660
    [Abstract] [Full Text] [Related]

  • 3. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.
    Dell'albani P, Rodolico M, Pellitteri R, Tricarichi E, Torrisi SA, D'Antoni S, Zappia M, Albanese V, Caltabiano R, Platania N, Aronica E, Catania MV.
    Neuro Oncol; 2014 Jan 01; 16(2):204-16. PubMed ID: 24305720
    [Abstract] [Full Text] [Related]

  • 4. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.
    Hu YY, Zheng MH, Cheng G, Li L, Liang L, Gao F, Wei YN, Fu LA, Han H.
    BMC Cancer; 2011 Feb 22; 11():82. PubMed ID: 21342503
    [Abstract] [Full Text] [Related]

  • 5. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
    Sun Z, Wang L, Zhou Y, Dong L, Ma W, Lv L, Zhang J, Wang X.
    Cell Mol Neurobiol; 2020 Jul 22; 40(5):767-784. PubMed ID: 31853695
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S, Das SK, Pradhan AK, Emdad L, Shen XN, Windle JJ, Sarkar D, Fisher PB.
    Oncotarget; 2016 Aug 23; 7(34):54102-54119. PubMed ID: 27472461
    [Abstract] [Full Text] [Related]

  • 8. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
    Singh DK, Shivalingappa PKM, Sharma A, Mondal A, Muzumdar D, Shiras A, Bapat SA.
    J Neurooncol; 2022 May 23; 157(3):575-591. PubMed ID: 35430703
    [Abstract] [Full Text] [Related]

  • 9. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
    Li X, Tao Z, Wang H, Deng Z, Zhou Y, Du Z.
    Exp Cell Res; 2020 Nov 01; 396(1):112261. PubMed ID: 32896567
    [Abstract] [Full Text] [Related]

  • 10. Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
    Shen Y, Chen H, Zhang J, Chen Y, Wang M, Ma J, Hong L, Liu N, Fan Q, Lu X, Tian Y, Wang A, Dong J, Lan Q, Huang Q.
    PLoS One; 2015 Nov 01; 10(11):e0142594. PubMed ID: 26599017
    [Abstract] [Full Text] [Related]

  • 11. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C, Boulay JL, Ivanek R, Alvarado A, Tostado C, Lugert S, Tchorz J, Coban M, Mariani L, Bettler B, Lathia J, Frank S, Pfister S, Kool M, Taylor V.
    Cancer Cell; 2015 Dec 14; 28(6):730-742. PubMed ID: 26669487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E, Lang V, Bohlen J, Bethke F, Puccio L, Tichy D, Herold-Mende C, Hielscher T, Lichter P, Goidts V.
    Int J Cancer; 2016 Oct 15; 139(8):1776-87. PubMed ID: 27299852
    [Abstract] [Full Text] [Related]

  • 15. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N, Agasse F, Armstrong D, Peng L, Commins D, Wang W, Rosenstein-Sisson R, Vaikari VP, Santiago SV, Santos T, Chen L, Schönthal AH, Chen TC, Hofman FM.
    Cancer Lett; 2016 Feb 28; 371(2):240-50. PubMed ID: 26683773
    [Abstract] [Full Text] [Related]

  • 16. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells.
    Lin Y, Sun H, Dang Y, Li Z.
    Oncol Rep; 2018 Feb 28; 39(2):687-694. PubMed ID: 29251326
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.
    Dantas-Barbosa C, Bergthold G, Daudigeos-Dubus E, Blockus H, Boylan JF, Ferreira C, Puget S, Abely M, Vassal G, Grill J, Geoerger B.
    Anticancer Drugs; 2015 Mar 28; 26(3):272-83. PubMed ID: 25486598
    [Abstract] [Full Text] [Related]

  • 18. Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells.
    Falk R, Falk A, Dyson MR, Melidoni AN, Parthiban K, Young JL, Roake W, McCafferty J.
    Methods; 2012 Sep 28; 58(1):69-78. PubMed ID: 22842086
    [Abstract] [Full Text] [Related]

  • 19. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L, Zhou X, Li T, Liu P, Hai L, Tong L, Ma H, Tao Z, Xie Y, Zhang C, Yu S, Yang X.
    J Exp Clin Cancer Res; 2019 Aug 05; 38(1):339. PubMed ID: 31382985
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.